{"database": "lobbying", "table": "lobbying_activities", "rows": [[1231610, "585919ec-d229-48c0-b23e-51b5c462365b", "Q1", "TURNER & GOSS LLP", 316310, "CYSTIC FIBROSIS FOUNDATION", 2012, "first_quarter", "MED", "Legislation reauthorizing the Prescription Drug User Fee Act\nS.2281/HR 4156, Expanding and Promoting Expertise in Review of Rare Treatments Act", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2012-04-18T11:38:40.420000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1231610"], "units": {}, "query_ms": 0.5749879928771406, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}